Silencing galectin 1 protein shrinks liver cancer tumors in mice

Researchers at UC Davis Comprehensive Cancer Center have shown that inhibiting a specific protein using gene therapy can shrink hepatocellular carcinoma (HCC) in mice.

First ‘blueprint’ of human skeletal development offers new insights into bone formation

The first ‘blueprint’ of human skeletal development reveals how the skeleton forms, shedding light on the process of arthritis, and highlighting cells involved in conditions

November 21, 2024

Novo Nordisk pulls filings for Wegovy in heart failure as it waits for cardiovascular outcomes data

Novo Nordisk is pulling its regulatory submissions to expand the use of its obesity drug Wegovy for a common type of heart failure, saying that

August 7, 2024

LoQus23 secures $43m to advance Huntington’s Disease therapy – Pharmaceutical Technology

By targeting a dysfunctional DNA repair system, inhibitors could slow or halt the progression of Huntington’s disease. Image: Shutterstock/ Andrii Yalanskyi. LoQus23 closed a round

October 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.